Publications
1. Singh SD, Tutuncu A,
Lohr I, Carlholm M, Polanowski T. Budesonide administered using
chlorofluorocarbon and hydrofluoroalkane pressurized metered-dose
inhalers; pharmacokinetics, pharmacodynamics and clinical
equivalence. International Journal Of Clinical Pharmacology and
Therapeutics 2007;45:485-495
2. Singh SD, Richards D,
Knowles RG, Schwartz S, Woodcock AA, Langley SJ, O’Connor BJ.
Selective inducible nitric oxide synthase inhibition has no effect
on allergen challenge in asthma. AJCCM 2007:18;46;22
3. Borrill ZL, Houghton
CM, Tal-Singer R, Vessey SR, Faiferman I, Langley SJ, Singh D. The
use of plethysmography and oscillometry to compare long acting
bronchodilators in patients with COPD. British J Clin Pharmacol in
press 2007
4. Smyth LJ, Starkey C,
Vestbo J, Singh D. CD4 regulatory cells in COPD patients. Chest
2007;132:156-63
5. Houghton CM, Lawson
N, Borrill ZL, Wixon C L, Yoxall SQ, Langley SJ, Woodcock AA, Singh
SD. Respiratory Research 2007;8:52
6. Roy K, Borrill ZL,
Starkey C, Hazel AL, Morris J, Vestbo J, Singh SD. Use of different
exhaled nitric oxide multiple flow rate models in COPD. Eur Respir J
2007;29:651-659.
7. Singh SD, Tal-Singer
R, Faiferman I, Lasenby S, Henderson A, Wessels D, Goosen A, Dallow
N, Vessey R, Goldman M. Plethysmography And Impulse Oscillometry
Assessment Of Tiotropium And Ipratropium Bromide; A Randomised,
Double Blind, Placebo Controlled, Crossover Study In Healthy
Subjects. British Journal Of Clinical Pharmacology. Br J Clin
Pharmacol. 2006;61:398-404
8. Borrill ZL, Clough D,
Truman N, Morris J, Langley SJ, Singh SD. A comparison of exhaled
nitric oxide measurements performed using 3 different analysers.
Respiratory Medicine 2006;100:1392-6
9. Borrill ZL, Houghton
CM, Woodcock AA, Vestbo J, Singh SD “Measuring bronchodilation in
COPD clinical trials.” British Journal Of Clinical Pharmacology
2005;59:379-84
10. Borrill ZL, Starkey
C, Vestbo J, Singh SD “Reproducibility Of Exhaled Breath Condensate
pH In Chronic Obstructive Pulmonary Disease.” European Respiratory
Journal 2005;25:269-74
11. Houghton CM,
Woodcock AA, Singh SD. “A Comparison Of Plethysmography, Spirometry
And Oscillometry For Assessing The Pulmonary Effects Of Inhaled
Ipratropium Bromide In Healthy Subjects And Patients With Asthma.”
British Journal Of Clinical Pharmacology 2005;59:152-9
12. Houghton CM,
Woodcock AA, Singh SD. “A comparison of lung function methods for
assessing dose-response effects of salbutamol” British Journal Of
Clinical Pharmacology. 2004;58:134-41.
13. Houghton CM, Langley
SJ, Singh SD, Holden J, Monici Preti AP, Acerbi D, Poli G, Woodcock
A. Comparison of bronchoprotective and bronchodilator effects of a
single dose of formoterol delivered by hydrofluoroalkane and
chlorofluorocarbon aerosols and dry powder in a double - blind,
placebo - controlled, cross-over study. Br J Clin Parmacol 2004;
58:4: 359-66
14. Kips JC, O'Connor
BJ, Langley SJ, Woodcock A, Kerstjens HAM, Postma DS, Danzig M, Cuss
F, Pauwels RA. The effect of SCH55700, a humanized anti-human IL-5
antibody in severe persistent asthma : a pilot study. Am J Respir
Crit Care Med 2003;167:1655-1659

15. A. Woodcock, A. Williams, L. Batty, C. Masterson, A. Rossetti
and L. Cantini. Effects of Lung Function, Symptoms, and Bronchial
Hyperreactivity of Low-Dose Inhaled Beclomethasone Dipropionate
Given with HFA-134a or CFC Propellant. Journal of Aerosol Medicine,
Volume 15, Number 4, 2002. Pp. 407-414.
16. Stephen J Langley,
Janet Holden, Alison Derham, Paul Hedgeland, Raj K Sharma, Ashley
Woodcock. Fluticasone propionate via the DiskhalerŪ or HFA-134a MDI
on Methacholine induced airway hyper-responsiveness. Chest 2002;
122: 806-811

17. Singh SD, C Whale, N Houghton, P Daley-Yates, SM Kirby, J
Efthimiou, AA Woodcock. Pharmacokinetics and systemic effects of
inhaled fluticasone propionate in chronic obstructive pulmonary
disease and healthy volunteers: a randomised crossover study. Br J
Clin Pharmacol. 2003 Apr;55(4):375-81.
18. Langley SJ, Sykes
AP, Batty EP, Masterson CM, Woodcock A. A Comparison Of The Efficacy
and Tolerability of Single Doses of HFA 134a Albuterol and CFC
Albuterol in Mild to Moderate Asthmatic Patients. Ann Allergy Asthma
and Immunol 2002 May;88(5):488-93

19. Brutsche MH, Carlen-Brutsche I, Munavar M, Langley SJ, Masterson
CM, Daley-Yates PT, Brown R, Custovic A, Woodcock A. Comparison of
pharmacokinetics and systemic effects of inhaled fluticasone
propionate in patients with asthma and healthy volunteers: a
randomised crossover study. Lancet 2000 Aug 12;356(9229);556-61.
20. Langley S J,
Masterson C M, Batty E P, Woodcock A. Bronchodilator Response to
salbutamol after chronic dosing with salmeterol. Eur Respir J
1998, 11:1081-1085.

|